Verastem, Inc. (VSTM)

6.385 +0.24 (+3.82%) USD  |  NASDAQ  |  Mar 06, 16:00
6.385 0.00 (0.00%) After-Hours: 18:30
More

Verastem Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Amgen, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Immuneering Corp. --
Tango Therapeutics, Inc. Upgrade